No abstract

Los lípidos de los alimentos cumplen un papel fundamental en nutrición humana. Con base en los potenciales efectos perjudiciales para la salud de las dietas altas en ácidos grasos trans (AGT) y la necesidad de contar con información sobre los niveles en alimentos de consumo local, se han investigado el contenido de AGT por espectrometría infrarroja, grasas totales y el porcentaje de AGT con respecto a lípidos totales en algunos alimentos procesados y materia prima grasa comercializados en cuatro ciudades de zonas urbanas del Paraguay. De los 28 tipos de alimentos analizados, el 84,7% contenía ≥0,2 gAGT/porción. Alrededor del 79% superó 5% de AGT totales en el contenido lipídico del alimento, nivel superior al recomendado actualmente por la OMS. En las muestras de materia prima grasa, se encontraron niveles excepcionalmente altos de AGT totales (77,6%) en comparación con los niveles recomendados (5%). Este trabajo presenta los primeros datos sobre el contenido de AGT en alimentos tradicionales de consumo en Paraguay como la chipa 1 , y destaca la importancia del control de la composición de los alimentos de venta local y sin etiquetado, así como la necesidad de apuntar a la reformulación de estos alimentos, con menores niveles de AGT con base en las recomendaciones nutricionales actuales a nivel mundial para la prevención de enfermedades cardiovasculares. Palabras clave: Lípidos, ácidos grasos trans totales, alimentos procesados, espectrometría infrarroja. Processed foods as source of total trans fatty acids in urban areas of Paraguay A B S T R A C TThe food fats play a fundamental role in human nutrition. Based on the known adverse health effects of diets high in trans fatty acids (TFA) and the need for information on levels in food for local consumption, in this work we investigated the content of total lipids and total TFA in some processed foods and fat raw material commercialized in four cities in urban areas of Paraguay. Of the 28 types of foods analyzed, 84.7% contained ≥0.2 g TFA/serving. Approximately 79% exceeded 5% of total TFA in food fat, which is higher than those levels currently recommended by the WHO. In raw material fat samples, exceptionally high levels of total TFA were found (77.6%) compared to the recommended level (5%). This paper presents the first data on the content of TFA in traditional foods of consumption in Paraguay, as "chipa", and highlights the importance of the control of the composition of the foods of local sale and without labeling, as well as the need to point to the reformulation of these foods, with lower levels of trans fatty acids based on the current nutritional recommendations worldwide for the prevention of cardiovascular diseases.

No abstract

Medulloblastoma (MB) is the most common and aggressive paediatric brain tumour. Although the cure rate can be as high as 70%, current treatments (surgery, radio- and chemotherapy) excessively affect the patients’ quality of life. Relapses cannot be controlled by conventional or targeted treatments and are usually fatal. The strong heterogeneity of the disease (four subgroups and several subtypes) is related to innate or acquired resistance to reference treatments. Therefore, more efficient and less-toxic therapies are needed. Here, we demonstrated the efficacy of a novel inhibitor (C29) of CXCR1/2 receptors for ELR+CXCL cytokines for the treatment of childhood MB. The correlation between ELR+CXCL/CXCR1/2 expression and patient survival was determined using the R2: Genomics Analysis and Visualization platform. In vitro efficacy of C29 was evaluated by its ability to inhibit proliferation, migration, invasion, and pseudo-vessel formation of MB cell lines sensitive or resistant to radiotherapy. The growth of experimental MB obtained by MB spheroids on organotypic mouse cerebellar slices was also assayed. ELR+CXCL/CXCR1/2 levels correlated with shorter survival. C29 inhibited proliferation, clone formation, CXCL8/CXCR1/2-dependent migration, invasion, and pseudo-vessel formation by sensitive and radioresistant MB cells. C29 reduced experimental growth of MB in the ex vivo organotypic mouse model and crossed the blood–brain barrier. Targeting CXCR1/2 represents a promising therapeutic strategy for the treatment of paediatric MB in first-line treatment or after relapse following conventional therapy.